GLP-3

Retatrutide is a novel triple hormone receptor agonist that simultaneously activates GLP-1, GIP, and glucagon receptors for superior metabolic effects. This innovative approach produces enhanced appetite suppression, improved insulin sensitivity, and increased energy expenditure, potentially delivering 20-25% weight loss in clinical trials.

How it works

Simultaneous activation of GLP-1, GIP, and glucagon receptors creating synergistic metabolic effects through enhanced appetite suppression, improved insulin sensitivity, increased energy expenditure, and optimized fat oxidation pathways for superior weight management outcomes

Weight Loss – Glucose control – Cardiovascular Protection